Impilo is a Nordic investment company focused solely on investments in companies operating in the pharmaceutical, medical technology, healthcare services and other health-related industries. Our starting point is that our portfolio companies must contribute to a positive and sustainable development of the communities and markets in which they operate in order to remain successful in the long term. This is a conviction that is embedded in our investment strategy since it necessitates a deeper understanding and reduces risks. This way, Impilo invests in people’s opportunities to enjoy healthier lives in the future.
Company Details
- Employees
- 37
- Founded
- -
- Address
- Holländargatan 20, Stockholm,111 60,sweden
- Phone
- +46 8 401 00 60
- in****@****pilo.se
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- impilo.se
- Keywords
- Healthcare, Pharma, Medical device, Diagnostics, Healthcare IT, Investments, Care services, Healthcare services, Consumer health, Preventive health services.
- HQ
- Stockholm
Impilo Questions
Impilo's helpline number is +46 8 401 00 60
Impilo's website is impilo.se
Impilo's LinkedIn profile is https://se.linkedin.com/company/impilo
Impilo has
37 employees.
View email and phone details for 37
employees at Impilo.
Impilo's industry is
Venture Capital and Private Equity Principals
Impilo's top competitors are
Trill Impact,
Fsn Capital Partners,
Impilo,
Polaris Private Equity,
Financelab,
Eqt Group,
Immedica Pharma Ab,
Axcel,
Nordic Capital,
Altor Equity Partners.
Impilo's support email address is info@impilo.se
Impilo's categories are Venture Capital and Private Equity Principals
Impilo's founding year is 2017
